Arbelaez Maria Clara, Arba Mosquera Samuel
Muscat Eye Laser Center, Muscat, Sultanate of Oman.
Middle East Afr J Ophthalmol. 2009 Jan;16(1):46-53. doi: 10.4103/0974-9233.48868.
To describe and argument an overview of the main features and unique technical points of AMARIS Total-Tech Laser, coupled with patient outcomes supporting the decision to perform LASIK treatments with maximised outcomes.
Dr. M.C. Arbelaez, Muscat Eye Laser Center, Muscat, Sultanate of Oman.
The findings collected during 18-month experience using SCHWIND AMARIS Total-Tech Laser have been reviewed to provide arguments for supporting the decision to perform LASIK treatments with maximised outcomes. For updated clinical outcomes, the last 100 myopic astigmatism treatments, the last 100 hyperopic astigmatism treatments, the last 30 ocular-wavefront-guided treatments, and the last 30 corneal-wavefront-guided treatments, all with 6-month follow-up, were included. For all those, LDV femtosecond system was used to prepare the flaps, and AMARIS flying spot system was used to perform ablations. Clinical outcomes were evaluated in terms of predictability, refractive outcome, safety, wavefront aberration, and contrast sensitivity.
6-month postoperatively, mean defocus was -0.14+/-0.31D and astigmatism 0.25+/-0.37D. 70+/- eyes were within +/-0.25D of emmetropia. 43+/- eyes gained lines of best spectacle-corrected visual acuity. For Aberration-Free treatments, none of the aberration metrics changed from pre- to postoperative values in a clinically relevant amount. For ocular-wavefront-guided treatments, the surgery did not change coma or spherical aberration, and reduced trefoil (p<0.005). For corneal-wavefront-guided treatments, the trefoil, coma, and spherical aberrations, as well as the total root-mean-square values of higher order aberration, were significantly reduced (p<.05) when the pre-existing aberrations were greater than the repeatability and the biological noise.
Although this review does not allow for evidence-based conclusions, following our strategy, LASIK results were excellent. LASIK surgery with AMARIS system yield excellent outcomes. Refractions were reduced to subclinical values with no induction of High-Order-Aberrations. Neither adverse events nor complications were observed.
描述并论证阿玛里斯全技术激光的主要特点和独特技术要点概述,同时结合患者治疗结果,为以最大化治疗效果进行准分子原位角膜磨镶术(LASIK)治疗的决策提供支持。
阿曼苏丹国马斯喀特市马斯喀特眼科激光中心的M.C.阿尔韦拉埃斯医生。
回顾了使用施温德阿玛里斯全技术激光18个月期间收集的研究结果,为以最大化治疗效果进行LASIK治疗的决策提供支持依据。为获取最新临床结果,纳入了最后100例近视散光治疗、最后100例远视散光治疗、最后30例眼波前引导治疗以及最后30例角膜波前引导治疗,所有治疗均有6个月的随访期。对于所有这些治疗,使用LDV飞秒系统制作角膜瓣,使用阿玛里斯飞点系统进行切削。从可预测性、屈光结果、安全性、波前像差和对比敏感度方面评估临床结果。
术后6个月,平均散焦为-0.14±0.31D,散光为0.25±0.37D。70±只眼处于正视眼±0.25D范围内。43±只眼的最佳矫正视力提高了行数。对于无像差治疗,在临床相关量上,术前到术后的像差指标均未改变。对于眼波前引导治疗,手术未改变彗差或球差,并减少了三叶草像差(p<0.005)。对于角膜波前引导治疗,当术前存在的像差大于重复性和生物噪声时,三叶草像差、彗差和球差以及高阶像差的总均方根值均显著降低(p<0.05)。
尽管本综述无法得出基于证据的结论,但按照我们的策略,LASIK手术效果极佳。使用阿玛里斯系统进行LASIK手术取得了优异的结果。屈光度降低至亚临床值,且未诱发高阶像差。未观察到不良事件或并发症。